Almased100Protein-rich Meal Replacement for Weight and HbA1c Reduction in Type 2 Diabetes Patients on High Insulin Dosage
This early phase study aims to evaluate if a protein-rich meal replacement can reduce daily insulin demand and improve HbA1c levels in individuals with type 2 diabetes who are on high insulin dosage.
Almased
Diabetes Mellitus+8
+ Endocrine System Diseases
+ Hyperinsulinism
Supportive Care Study
Summary
Study start date: July 1, 2009
Actual date on which the first participant was enrolled.The pilot study included patients with type 2 diabetes (n=22), that injected >100 U insulin daily. During the first week, all three main meals were replaced with 50 g of a protein-rich meal replacement (Almased) (=1100 kcal per day). During weeks 2-4, only two meals were replaced and a protein-rich lunch was allowed. During weeks 5-12, only dinner was replaced. Clinical parameters were determined at the beginning of the study, after 4, 8 and 12 weeks as well as after 1.5 years of follow-up. Wilcoxon signed rank test was used for the intention-to-treat analysis and Mann-Whitney test for subgroup analyses.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.22 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Supportive Care Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.From 35 to 75 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.One single intervention group is designated in this study
This study does not include a placebo group
Treatment Groups
Group I
ExperimentalStudy Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location
West German Center of Diabetes and Health
Düsseldorf, GermanyOpen West German Center of Diabetes and Health in Google Maps